Hydrogenology
Source-linked study record

Hydrogen inhalation ameliorates lung inflammation in mice with asthma

Li H et al. · Eur J Med Res. 2025;30:1024.

PreclinicalOther formsPublished 2025Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Female C57BL/6 mice sensitized and challenged with ovalbumin

Intervention and dose

Whole-body exposure to 15% H₂ in air for 1 hour daily over 7 consecutive days · 15% H₂ in air at a reported total chamber flow of 4 L/min.

Duration

One hour daily for 7 consecutive days

Reported result

The article reports lower airway responsiveness, inflammation, IgE and MDA and higher SOD and regulatory-cytokine expression with H₂.

Main limitation

Small preclinical asthma model. The 600 mL/min figure is a calculated H₂ component of chamber flow, not a separately measured animal inspired-flow value.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized mouse ovalbumin-asthma experiment

Research topic

Respiratory health

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Female C57BL/6 mice sensitized and challenged with ovalbumin

Sample

32 mice; the article describes groups of eight

Duration

One hour daily for 7 consecutive days

Intervention

Whole-body exposure to 15% H₂ in air for 1 hour daily over 7 consecutive days

Hydrogen form

H₂ diluted in air — not Brown’s gas.

Dose or H₂ specification

15% H₂ in air at a reported total chamber flow of 4 L/min.

Comparator

Ovalbumin-asthma mice exposed to ambient atmosphere, plus non-asthmatic controls

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Airway responsiveness, type-2 cytokines, IgE, regulatory cytokines, lung histology, MDA and SOD

Reported result

The article reports lower airway responsiveness, inflammation, IgE and MDA and higher SOD and regulatory-cytokine expression with H₂.

Extraction completeness

Allocation, concentration, total flow, timing, outcomes, funding and conflicts checked in the open-access full text.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small preclinical asthma model. The 600 mL/min figure is a calculated H₂ component of chamber flow, not a separately measured animal inspired-flow value.

Applies directly to

Ovalbumin-induced airway inflammation in mice, not clinical asthma.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 41146240 · DOI: 10.1186/s40001-025-03296-7

Publisher access

Open-access full text is available through PMC and the publisher.

Extraction basis

Open-access publisher/PMC full text and PubMed record; no retraction or expression of concern was shown in the checked records on 7 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.